| Financial Year |
March 31 2023 |
| Monetary Funds |
1,615,991,630.35 |
| Held-for-trading Financial Assets |
300,962,033.33 |
| Notes Receivable |
1,204,891,091.30 |
| Accounts Receivable |
1,296,059,880.09 |
| Advances to Suppliers |
26,177,729.65 |
| Other Receivables |
2,792,735.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,844,042,185.51 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
47,348,117.48 |
| Total Current Assets |
6,431,258,787.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,296,230,454.60 |
| Under-construction Projects |
318,933,783.03 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
262,640,059.66 |
| R&D expenses |
22,811,297.70 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,689,235.22 |
| Deferred Income Tax Assets |
198,069,249.61 |
| Other Non-Current Assets |
180,556,513.55 |
| Sub-Total of Non-Current Assets |
2,308,305,496.85 |
| Total Assets |
8,739,564,284.69 |
| Short-Term Loans |
225,438,148.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,590,966,007.68 |
| Accounts Payable |
647,405,697.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
102,843,130.99 |
| Taxes Payable |
4,924,658.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,799,107.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,084,942.26 |
| Other Current Liabilities |
24,578,772.09 |
| Sub-Total of Current Liabilities |
3,713,824,704.62 |
| Long-term Loans |
-- |
| Bonds Payable |
1,055,061,714.52 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,632,508.18 |
| Deferred Income Tax Liabilities |
11,414,777.38 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,230,302,310.38 |
| Total Liabilities |
4,944,127,015.00 |
| Paid-In Capital(Or Share Stock) |
820,216,556.00 |
| Capital Surplus |
1,285,399,951.66 |
| Surplus Reserve |
232,311,809.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,039,823,315.09 |
| Minority Stockholder's Interest |
43,619,028.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,751,818,241.25 |
| Owner's Equity（Stockholder's Equity） |
3,795,437,269.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,739,564,284.69 |
